A monocenter, non-controlled, non-randomized IST to compare bioavailability of Kaletra soft-gel capsules or -suspension to Kaletra tablets in pediatric patients – C2T [Eine monozentrische, nicht kontrollierte, nicht randomisierte IST zur vergleichenden Bioverfugbarkeit von Kaletra-Softgelkapseln oder –Losung und Kaletra-Tabletten in padiatrischen Patienten – 'C2T'

Trial Profile

A monocenter, non-controlled, non-randomized IST to compare bioavailability of Kaletra soft-gel capsules or -suspension to Kaletra tablets in pediatric patients – C2T [Eine monozentrische, nicht kontrollierte, nicht randomisierte IST zur vergleichenden Bioverfugbarkeit von Kaletra-Softgelkapseln oder –Losung und Kaletra-Tabletten in padiatrischen Patienten – 'C2T'

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2014

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jun 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 07 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top